Literature DB >> 17258832

Characterization of lobulated fibers in limb girdle muscular dystrophy type 2A by gene expression profiling.

Yoko Keira1, Satoru Noguchi, Rumi Kurokawa, Masako Fujita, Narihiro Minami, Yukiko K Hayashi, Takashi Kato, Ichizo Nishino.   

Abstract

Limb girdle muscular dystrophy type 2A (LGMD2A) is caused by mutations in CAPN3, which encodes an intracellular cysteine protease. To elucidate the fundamental molecular changes that may be responsible for the pathological features of LGMD2A, we employed cDNA microarray analysis. We divided LGMD2A muscles into two groups according to specific pathological features: an early-stage group characterized by the presence of active necrosis and a regeneration process and a later-stage group characterized by the presence of lobulated fibers. After comparing the gene expression profiles of the two groups of LGMD2A muscles with control muscles, we identified 29 genes whose mRNA expression profiles were specifically altered in muscles with lobulated fibers. Interestingly, this group included genes that encode actin filament binding and regulatory proteins, such as gelsolin, PDZ and LIM domain 3 (PDLIM3) and troponin I1. Western blot analysis confirmed the upregulation of these proteins. From these results, we propose that abnormal increased expression of actin filament binding proteins may contribute to the changes of the intra-myofiber structures, observed in lobulated fibers in LGMD2A.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17258832     DOI: 10.1016/j.neures.2006.12.010

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  6 in total

1.  Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue.

Authors:  Frederic Raymond; Sylviane Métairon; Martin Kussmann; Jaume Colomer; Andres Nascimento; Emma Mormeneo; Cèlia García-Martínez; Anna M Gómez-Foix
Journal:  BMC Genomics       Date:  2010-02-22       Impact factor: 3.969

2.  Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation.

Authors:  Xiomara Q Rosales; Vinod Malik; Amita Sneh; Lei Chen; Sarah Lewis; Janaiah Kota; Julie M Gastier-Foster; Caroline Astbury; Rob Pyatt; Shalini Reshmi; Louise R Rodino-Klapac; K Reed Clark; Jerry R Mendell; Zarife Sahenk
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

3.  Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A.

Authors:  M Fanin; L Nardetto; A C Nascimbeni; E Tasca; M Spinazzi; R Padoan; C Angelini
Journal:  J Med Genet       Date:  2007-05-25       Impact factor: 6.318

4.  Gene expression profiling in limb-girdle muscular dystrophy 2A.

Authors:  Amets Sáenz; Margarita Azpitarte; Rubén Armañanzas; France Leturcq; Ainhoa Alzualde; Iñaki Inza; Federico García-Bragado; Gaspar De la Herran; Julián Corcuera; Ana Cabello; Carmen Navarro; Carolina De la Torre; Eduard Gallardo; Isabel Illa; Adolfo López de Munain
Journal:  PLoS One       Date:  2008-11-18       Impact factor: 3.240

Review 5.  The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Front Aging Neurosci       Date:  2014-08-29       Impact factor: 5.750

6.  Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.

Authors:  Sonia Paco; Susana G Kalko; Cristina Jou; María A Rodríguez; Joan Corbera; Francesco Muntoni; Lucy Feng; Eloy Rivas; Ferran Torner; Francesca Gualandi; Anna M Gomez-Foix; Anna Ferrer; Carlos Ortez; Andrés Nascimento; Jaume Colomer; Cecilia Jimenez-Mallebrera
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.